Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells
Tóm tắt
Diabetes mellitus causes a progressive loss of functional efficacy in stem cells, including cardiac progenitor cells (CPCs). The underlying molecular mechanism is still not known. MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate genes at the post-transcriptional level. We aimed to determine if diabetes mellitus induces dysregulation of miRNAs in CPCs and to test if in vitro therapeutic modulation of miRNAs would improve the functions of diabetic CPCs. CPCs were isolated from a mouse model of type 2 diabetes (db/db), non-diabetic mice and human right atrial appendage heart tissue. Total RNA isolated from mouse CPCs was miRNA profiled using Nanostring analysis. Bioinformatic analysis was employed to predict the functional effects of altered miRNAs. MS analysis was applied to determine the targets, which were confirmed by western blot analysis. Finally, to assess the beneficial effects of therapeutic modulation of miRNAs in vitro and in vivo, prosurvival miR-30c-5p was overexpressed in mouse and human diabetic CPCs, and the functional consequences were determined by measuring the level of apoptotic cell death, cardiac function and mitochondrial membrane potential (MMP). Among 599 miRNAs analysed in mouse CPCs via Nanostring analysis, 16 miRNAs showed significant dysregulation in the diabetic CPCs. Using bioinformatics tools and quantitative real-time PCR (qPCR) validation, four altered miRNAs (miR-30c-5p, miR-329-3p, miR-376c-3p and miR-495-3p) were identified to play an important role in cell proliferation and survival. Diabetes mellitus significantly downregulated miR-30c-5p, while it upregulated miR-329-3p, miR-376c-3p and miR-495-3p. MS analysis revealed proapoptotic voltage-dependent anion-selective channel 1 (VDAC1) as a direct target for miR-30c-5p, and cell cycle regulator, cyclin-dependent protein kinase 6 (CDK6), as the direct target for miR-329-3p, miR-376c-3p and miR-495-3p. Western blot analyses showed a marked increase in VDAC1 expression, while CDK6 expression was downregulated in diabetic CPCs. Finally, in vitro and in vivo overexpression of miR-30c-5p markedly reduced the apoptotic cell death and preserved MMP in diabetic CPCs via inhibition of VDAC1. Our results demonstrate that diabetes mellitus induces a marked dysregulation of miRNAs associated with stem cell survival, proliferation and differentiation, and that therapeutic overexpression of prosurvival miR-30c-5p reduced diabetes-induced cell death and loss of MMP in CPCs via the newly identified target for miR-30c-5p, VDAC1.
Tài liệu tham khảo
World Heart Federation (2020) The world's most common cause of death. Available from www.world-heart-federation.org/wp-content/uploads/2017/05/WCC2016_CVDs_infographic-1.pdf. Accessed Feb 2020
Isomi M, Sadahiro T, Ieda M (2019) Progress and challenge of cardiac regeneration to treat heart failure. J Cardiol 73:97–101. https://doi.org/10.1016/j.jjcc.2018.10.002
Satthenapalli VR, Lamberts RR, Katare RG (2017) Concise review: Challenges in regenerating the diabetic heart: A comprehensive review. Stem Cells 35:2009–2026. https://doi.org/10.1002/stem.2661
Tzahor E, Poss KD (2017) Cardiac regeneration strategies: Staying young at heart. Science 356:1035–1039. https://doi.org/10.1126/science.aam5894
The Lancet Editors (2014) Expression of concern: The SCIPIO trial. Lancet 383:1279. https://doi.org/10.1016/S0140-6736(14)60608-5
The American Heart Association (2019) Retraction of: Cardiomyogenesis in the developing heart is regulated by C-kit-positive cardiac stem cells. Circ Res 124:e28. https://doi.org/10.1161/RES.0000000000000252
The American Heart Association (2019) Retraction of: Role of cardiac stem cells in cardiac pathophysiology: A paradigm shift in human myocardial biology. Circ Res 124:e24. https://doi.org/10.1161/RES.0000000000000248
Gude NA, Sussman MA (2019) Cardiac regenerative therapy: Many paths to repair. Trends Cardiovasc Med 30(6):338–343
Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ (2004) Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110:3300–3305. https://doi.org/10.1161/01.CIR.0000147780.30124.CF
Hatzistergos KE, Saur D, Seidler B et al (2016) Stimulatory effects of mesenchymal stem cells on cKit+ cardiac stem cells are mediated by SDF1/CXCR4 and SCF/cKit signaling pathways. Circ Res 119:921–930. https://doi.org/10.1161/CIRCRESAHA.116.309281
Katare R, Oikawa A, Cesselli D et al (2013) Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes. Cardiovasc Res 97:55–65. https://doi.org/10.1093/cvr/cvs291
Khaksar M, Sayyari M, Rezaie J, Pouyafar A, Montazersaheb S, Rahbarghazi R (2018) High glucose condition limited the angiogenic/cardiogenic capacity of murine cardiac progenitor cells in in vitro and in vivo milieu. Cell Biochem Funct 36:346–356. https://doi.org/10.1002/cbf.3354
Mehra P, Guo Y, Nong Y et al (2018) Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair. Basic Res Cardiol 113:46
Palomer X, Pizarro-Delgado J, Vazquez-Carrera M (2018) Emerging actors in diabetic cardiomyopathy: Heartbreaker biomarkers or therapeutic targets? Trends Pharmacol Sci 39:452–467. https://doi.org/10.1016/j.tips.2018.02.010
Rawal S, Nagesh PT, Coffey S et al (2019) Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium. Cardiovasc Diabetol 18:13
Hathaway QA, Pinti MV, Durr AJ, Waris S, Shepherd DL, Hollander JM (2018) Regulating microRNA expression: At the heart of diabetes mellitus and the mitochondrion. Am J Physiol Heart Circ Physiol 314:H293–H310. https://doi.org/10.1152/ajpheart.00520.2017
Rawal S, Munasinghe PE, Shindikar A et al (2017) Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy. Cardiovasc Res 113:90–101. https://doi.org/10.1093/cvr/cvw235
Rawal S, Munasinghe PE, Nagesh PT et al (2017) Down-regulation of miR-15a/b accelerates fibrotic remodelling in the type 2 diabetic human and mouse heart. Clin Sci (Lond) 131:847–863. https://doi.org/10.1042/CS20160916
Fomison-Nurse I, Saw EEL, Gandhi S et al (2018) Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells. Cell Death Differ 25:1336–1349. https://doi.org/10.1038/s41418-017-0047-6
Gorabi AM, Bianconi V, Pirro M, Banach M, Sahebkar A (2019) Regulation of cardiac stem cells by microRNAs: State-of-the-art. Biomed Pharmacother 120:109447. https://doi.org/10.1016/j.biopha.2019.109447
Chandrasekera DNK, Neale JPH, van Hout I et al (2020) Upregulation of microRNA-532 enhances cardiomyocyte apoptosis in the diabetic heart. Apoptosis 25:388–399. https://doi.org/10.1007/s10495-020-01609-1
Lew JK, Pearson JT, Saw E et al (2020) Exercise regulates microRNAs to preserve coronary and cardiac function in the diabetic heart. Circ Res 127(11):1384–1400. https://doi.org/10.1161/CIRCRESAHA.120.317604
Dixit P, Katare RG (2019) Isolation and characterization of cardiac progenitor cells. Methods Mol Biol 2029:161–173
Rawal S, Ram TP, Coffey S et al (2016) Differential expression pattern of cardiovascular microRNAs in the human type-2 diabetic heart with normal ejection fraction. Int J Cardiol 202:40–43. https://doi.org/10.1016/j.ijcard.2015.08.161
Manning P, Munasinghe PE, Bellae Papannarao J, Gray AR, Sutherland W, Katare R (2019) Acute weight loss restores dysregulated circulating MicroRNAs in individuals who are obese. J Clin Endocrinol Metab 104:1239–1248. https://doi.org/10.1210/jc.2018-00684
Paraskevopoulou MD, Georgakilas G, Kostoulas N et al (2013) DIANA-microT web server v5.0: Service integration into miRNA functional analysis workflows. Nucleic Acids Res 41:W169–W173. https://doi.org/10.1093/nar/gkt393
Wong N, Wang X (2015) miRDB: An online resource for microRNA target prediction and functional annotations. Nucleic Acids Res 43:D146–D152. https://doi.org/10.1093/nar/gku1104
Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA.Org resource: Targets and expression. Nucleic Acids Res 36:D149–D153. https://doi.org/10.1093/nar/gkm995
Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4:e05005
Szklarczyk D, Morris JH, Cook H et al (2017) The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45:D362–D368. https://doi.org/10.1093/nar/gkw937
Hom JR, Quintanilla RA, Hoffman DL et al (2011) The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. Dev Cell 21:469–478
Esfandiari F, Fathi A, Gourabi H, Kiani S, Nemati S, Baharvand H (2012) Glycogen synthase kinase-3 inhibition promotes proliferation and neuronal differentiation of human-induced pluripotent stem cell-derived neural progenitors. Stem Cells Dev 21:3233–3243. https://doi.org/10.1089/scd.2011.0678
Li H, Radford JC, Ragusa MJ et al (2008) Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo. Proc Natl Acad Sci U S A 105:9397–9402
Scheicher R, Hoelbl-Kovacic A, Bellutti F et al (2015) CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. Blood 125:90–101. https://doi.org/10.1182/blood-2014-06-584417
Shore GC (2009) Apoptosis: it's BAK to VDAC. EMBO Rep 10:1311–1313. https://doi.org/10.1038/embor.2009.249
Rota M, LeCapitaine N, Hosoda T et al (2006) Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res 99:42–52. https://doi.org/10.1161/01.RES.0000231289.63468.08
Noseda M, Harada M, McSweeney S et al (2015) PDGFRalpha demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium. Nat Commun 6:6930
Katare R, Caporali A, Zentilin L et al (2011) Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res 108:1238–1251. https://doi.org/10.1161/CIRCRESAHA.110.239111
Marunouchi T, Sasaki K, Yano E, Tanonaka K (2019) Transplantation of cardiac Sca-1-positive cells rather than c-Kit-positive cells preserves mitochondrial oxygen consumption of the viable myocardium following myocardial infarction in rats. J Pharmacol Sci 140:236–241. https://doi.org/10.1016/j.jphs.2019.07.005
Konemann S, Sartori LV, Gross S et al (2020) Cardioprotective effect of the secretome of Sca-1+ and Sca-1- cells in heart failure: Not equal, but equally important? Cardiovasc Res 116:566–575. https://doi.org/10.1093/cvr/cvz140
Dixit P, Donnelly H, Edamatsu M, Galvin I, Bunton R, Katare R (2017) Progenitor cells from atria, ventricle and peripheral blood of the same patients exhibit functional differences associated with cardiac repair. Int J Cardiol 228:412–421. https://doi.org/10.1016/j.ijcard.2016.11.178
Veldman-Jones MH, Brant R, Rooney C et al (2015) Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer Res 75:2587–2593. https://doi.org/10.1158/0008-5472.CAN-15-0262
Welten SM, Bastiaansen AJ, de Jong RC et al (2014) Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 increases neovascularization and blood flow recovery after ischemia. Circ Res 115:696–708. https://doi.org/10.1161/CIRCRESAHA.114.304747
Kureel J, John AA, Prakash R, Singh D (2018) MiR 376c inhibits osteoblastogenesis by targeting Wnt3 and ARF-GEF-1 -facilitated augmentation of beta-catenin transactivation. J Cell Biochem 119:3293–3303. https://doi.org/10.1002/jcb.26490
Lee S, Yoon DS, Paik S, Lee KM, Jang Y, Lee JW (2014) microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9. Stem Cells Dev 23:1798–1808. https://doi.org/10.1089/scd.2013.0609
Sun F, Fu H, Liu Q et al (2008) Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 582:1564–1568. https://doi.org/10.1016/j.febslet.2008.03.057
Duisters RF, Tijsen AJ, Schroen B et al (2009) miR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104:170–178, 176p following 178. https://doi.org/10.1161/CIRCRESAHA.108.182535
Raut SK, Singh GB, Rastogi B et al (2016) miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy. Mol Cell Biochem 417:191–203. https://doi.org/10.1007/s11010-016-2729-7
Naghdi S, Hajnoczky G (2016) VDAC2-specific cellular functions and the underlying structure. Biochim Biophys Acta 1863:2503–2514